MRNA vs NVAX — Performance Comparison
Side-by-side percent change for Moderna, Inc. (MRNA), Novavax, Inc. (NVAX) across every preset interval.
Over the past year, MRNA is up 105.0% versus NVAX up 45.55% — MRNA ahead by 59.48%. Over the past 30 days, NVAX is up 5.35% and MRNA is down 10.63%. MRNA trades at $48.49; NVAX at $9.16.
| Ticker | Price | 1D | 3D | 7D | 30D | 90D | YTD | 6M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MRNA Moderna, Inc. | $48.49 | -3.08% | -8.97% | -10.78% | -10.63% | +14.82% ★ | +64.43% ★ | +95.76% ★ | +105.03% ★ | -61.24% | -69.77% ★ |
| NVAX Novavax, Inc. | $9.16 | -2.09% ★ | -4.83% ★ | -9.45% ★ | +5.35% ★ | +5.23% | +36.24% | +31.35% | +45.55% | +19.83% ★ | -93.47% |
Want to zoom in?
Open the interactive Compare tool to overlay these tickers on a normalized chart, pin any two dates to see the exact return between them, and pick a custom interval.
Open in interactive CompareEach ticker's detail page
MRNAModerna, Inc.
$48.49-3.08% today
NVAXNovavax, Inc.
$9.16-2.09% today